Identification of Circulating MicroRNAs As Novel Potential Biomarkers for Gastric Cancer Detection: a Systematic Review and Meta-analysis

Overview

Journal Dig Dis Sci

Specialty Gastroenterology

Date 2013 Dec 17

PMID 24337687

Citations 33

Authors

Xingya Zhu

Mengmeng Lv

Hao Wang

Wenxian Guan

Affiliations

Soon will be listed here.

Abstract

Background: Recent studies show that microRNAs (miRNAs) in serum or plasma can be stably detected and used as potential biomarkers in cancer diagnosis.

Objectives: To systematically evaluate circulating miRNAs from numerous gastric cancer (GC) expression profiling studies and to determine miRNA biomarkers for GC detection.

Methods: A systematic review and meta-analysis of published studies comparing the circulating miRNA expressions between GC patients and healthy controls were carried out. An miRNA ranking system that considered the number of comparisons in agreement, total number of samples, and average fold change was used. Then the receiver-operating characteristic curve (ROC) results of the top miRNAs were combined to further evaluate their diagnostic value by using Meta-disc 1.4.

Results: A total of 35 miRNAs were reported in the 22 included studies, with 7 miRNAs reported in at least 2 studies. MiR-21 is the most consistently reported miRNA with upregulation. In further analysis, the sensitivity, specificity, and area under the curve of summary ROC for miR-21 in GC diagnosis are 0.78 (95 % CI 0.71-0.85), 0.89 (95 % CI 0.82-0.94), and 0.91, respectively.

Conclusion: Circulating miR-21 can serve as a potential biomarker for detection of GC.

Citing Articles

miR-122-IGF-1R signaling allied through the dysregulated lncRNA expression in gastric carcinoma.

Kadry M Toxicol Rep. 2024; 12:338-344.

PMID: 38544957 PMC: 10965482. DOI: 10.1016/j.toxrep.2024.03.005.

Identification of miR-143-3p as a diagnostic biomarker in gastric cancer.

Ju Y, Choi G, Lee M, Jeong M, Kwon H, Kim D BMC Med Genomics. 2023; 16(1):135.

PMID: 37328880 PMC: 10273760. DOI: 10.1186/s12920-023-01554-3.

Role of miRNAs in Neurodegeneration: From Disease Cause to Tools of Biomarker Discovery and Therapeutics.

Roy B, Lee E, Li T, Rampersaud M Genes (Basel). 2022; 13(3).

PMID: 35327979 PMC: 8951370. DOI: 10.3390/genes13030425.

Clinical Value of Serum Thrombospondin-2 Combined with CA19-9 in Early Diagnosis of Gastric Cancer.

Li L, Dong J, Fu L, Xia X, Pan F, Ning Y J Oncol. 2021; 2021:2483964.

PMID: 34659407 PMC: 8516522. DOI: 10.1155/2021/2483964.

The Physiological MicroRNA Landscape in Nipple Aspirate Fluid: Differences and Similarities with Breast Tissue, Breast Milk, Plasma and Serum.

Patuleia S, van Gils C, Oneto Cao A, Bakker M, van Diest P, van der Wall E Int J Mol Sci. 2020; 21(22).

PMID: 33187146 PMC: 7696615. DOI: 10.3390/ijms21228466.

References

Lo S, Hung P, Chen J, Tu H, Fang W, Chen C . Overexpression of miR-370 and downregulation of its novel target TGFβ-RII contribute to the progression of gastric carcinoma. Oncogene. 2011; 31(2):226-37. DOI: 10.1038/onc.2011.226. View

Konishi H, Ichikawa D, Komatsu S, Shiozaki A, Tsujiura M, Takeshita H . Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre- and post-operative plasma. Br J Cancer. 2012; 106(4):740-7. PMC: 3322946. DOI: 10.1038/bjc.2011.588. View

Shen J, Todd N, Zhang H, Yu L, Lingxiao X, Mei Y . Plasma microRNAs as potential biomarkers for non-small-cell lung cancer. Lab Invest. 2010; 91(4):579-87. PMC: 3130190. DOI: 10.1038/labinvest.2010.194. View

Vickers K, Palmisano B, Shoucri B, Shamburek R, Remaley A . MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol. 2011; 13(4):423-33. PMC: 3074610. DOI: 10.1038/ncb2210. View

Dong P, Kaneuchi M, Watari H, Sudo S, Sakuragi N . MicroRNA-106b modulates epithelial-mesenchymal transition by targeting TWIST1 in invasive endometrial cancer cell lines. Mol Carcinog. 2013; 53(5):349-59. DOI: 10.1002/mc.21983. View

Madhavan D, Cuk K, Burwinkel B, Yang R . Cancer diagnosis and prognosis decoded by blood-based circulating microRNA signatures. Front Genet. 2013; 4:116. PMC: 3689027. DOI: 10.3389/fgene.2013.00116. View

Zhang Q, Sun H, Zheng R, Li Y, Zhang Q, Cheng P . Meta-analysis of microRNA-183 family expression in human cancer studies comparing cancer tissues with noncancerous tissues. Gene. 2013; 527(1):26-32. DOI: 10.1016/j.gene.2013.06.006. View

Gorur A, Fidanci S, Dogruer Unal N, Ayaz L, Akbayir S, Yaroglu H . Determination of plasma microRNA for early detection of gastric cancer. Mol Biol Rep. 2012; 40(3):2091-6. DOI: 10.1007/s11033-012-2267-7. View

Griffith O, Melck A, Jones S, Wiseman S . Meta-analysis and meta-review of thyroid cancer gene expression profiling studies identifies important diagnostic biomarkers. J Clin Oncol. 2006; 24(31):5043-51. DOI: 10.1200/JCO.2006.06.7330. View

10.

Seevaratnam R, Bocicariu A, Cardoso R, Yohanathan L, Dixon M, Law C . How many lymph nodes should be assessed in patients with gastric cancer? A systematic review. Gastric Cancer. 2012; 15 Suppl 1:S70-88. DOI: 10.1007/s10120-012-0169-y. View

11.

McDonald J, Milosevic D, Reddi H, Grebe S, Algeciras-Schimnich A . Analysis of circulating microRNA: preanalytical and analytical challenges. Clin Chem. 2011; 57(6):833-40. DOI: 10.1373/clinchem.2010.157198. View

12.

Chan S, Griffith O, Tai I, Jones S . Meta-analysis of colorectal cancer gene expression profiling studies identifies consistently reported candidate biomarkers. Cancer Epidemiol Biomarkers Prev. 2008; 17(3):543-52. DOI: 10.1158/1055-9965.EPI-07-2615. View

13.

Ichikawa D, Komatsu S, Konishi H, Otsuji E . Circulating microRNA in digestive tract cancers. Gastroenterology. 2012; 142(5):1074-1078.e1. DOI: 10.1053/j.gastro.2012.03.008. View

14.

Yan Z, Xiong Y, Xu W, Gao J, Cheng Y, Wang Z . Identification of hsa-miR-335 as a prognostic signature in gastric cancer. PLoS One. 2012; 7(7):e40037. PMC: 3388997. DOI: 10.1371/journal.pone.0040037. View

15.

Li C, Li J, Cai Q, Qiu Q, Yan M, Liu B . MiRNA-199a-3p: A potential circulating diagnostic biomarker for early gastric cancer. J Surg Oncol. 2013; 108(2):89-92. DOI: 10.1002/jso.23358. View

16.

Zhou H, Guo J, Lou Y, Zhang X, Zhong F, Jiang Z . Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker. J Mol Med (Berl). 2010; 88(7):709-17. DOI: 10.1007/s00109-010-0617-2. View

17.

Cai H, Yuan Y, Hao Y, Guo T, Wei X, Zhang Y . Plasma microRNAs serve as novel potential biomarkers for early detection of gastric cancer. Med Oncol. 2013; 30(1):452. DOI: 10.1007/s12032-012-0452-0. View

18.

Zhou H, Xiao B, Zhou F, Deng H, Zhang X, Lou Y . MiR-421 is a functional marker of circulating tumor cells in gastric cancer patients. Biomarkers. 2012; 17(2):104-10. DOI: 10.3109/1354750X.2011.614961. View

19.

Blanco-Calvo M, Calvo L, Figueroa A, Haz-Conde M, Anton-Aparicio L, Valladares-Ayerbes M . Circulating microRNAs: molecular microsensors in gastrointestinal cancer. Sensors (Basel). 2012; 12(7):9349-62. PMC: 3444104. DOI: 10.3390/s120709349. View

20.

Liu H, Zhu L, Liu B, Yang L, Meng X, Zhang W . Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer. Cancer Lett. 2011; 316(2):196-203. DOI: 10.1016/j.canlet.2011.10.034. View